cAMPfield Therapeutics, Prifemilast, Newsoara Biopharma, Phase 3 Clinical Trial, Plaque Psoriasis, Apremilast, PDE4B Inhibitor, Dermatology, Immunology, Inflammatory Bowel Disease

San Diego, California, USA, October 9, 2026 cAMPfield Therapeutics has announced positive Phase 3 clinical trial results for prifemilast,...